Tyra Biosciences, Inc. Share Price
TYRATyra Biosciences, Inc. Stock Performance
Open $32.09 | Prev. Close $31.74 | Circuit Range N/A |
Day Range $29.37 - $32.09 | Year Range $9.10 - $40.42 | Volume 49,572 |
Average Traded $30.05 |
Tyra Biosciences, Inc. Share Price Chart
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Tyra Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
01-Jul-26 | $32.09 | $29.47 | +0.00% |
01-Jul-26 | $32.09 | $29.47 | -7.76% |
30-Jun-26 | $31.66 | $31.95 | -0.44% |
29-Jun-26 | $31.73 | $32.09 | +0.66% |
26-Jun-26 | $30.35 | $31.88 | +3.07% |
25-Jun-26 | $30.20 | $30.93 | +1.88% |
24-Jun-26 | $30.05 | $30.36 | +1.03% |